Literature DB >> 30605723

It's all about tau.

Cheril Tapia-Rojas1, Fabian Cabezas-Opazo2, Carol A Deaton3, Erick H Vergara2, Gail V W Johnson3, Rodrigo A Quintanilla4.   

Abstract

n class="Gene">Tau is a protein that is highly enriched in neurons and was originally defined by its ability to bind and stabilize microtubules. However, it is now becoming evident that the functions of tau extend beyond its ability to modulate microtubule dynamics. Tau plays a role in mediating axonal transport, synaptic structure and function, and neuronal signaling pathways. Although tau plays important physiological roles in neurons, its involvement in neurodegenerative diseases, and most prominently in the pathogenesis of Alzheimer disease (AD), has directed the majority of tau studies. However, a thorough knowledge of the physiological functions of tau and its post-translational modifications under normal conditions are necessary to provide the foundation for understanding its role in pathological settings. In this review, we will focus on human tau, summarizing tau structure and organization, as well as its posttranslational modifications associated with physiological processes. We will highlight possible mechanisms involved in mediating the turnover of tau and finally discuss newly elucidated tau functions in a physiological context.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axonal transport; Dendrites; Microtubules; Posttranslational modifications; Tau

Year:  2018        PMID: 30605723      PMCID: PMC6397676          DOI: 10.1016/j.pneurobio.2018.12.005

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  303 in total

1.  Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation.

Authors:  Min-Hua Luo; Michael L Leski; Athena Andreadis
Journal:  J Cell Biochem       Date:  2004-04-01       Impact factor: 4.429

2.  N-terminal fragments of tau inhibit full-length tau polymerization in vitro.

Authors:  Peleg M Horowitz; Nichole LaPointe; Angela L Guillozet-Bongaarts; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2006-10-24       Impact factor: 3.162

3.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

4.  Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.

Authors:  E Bednarski; G Lynch
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

5.  Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments.

Authors:  T Maas; J Eidenmüller; R Brandt
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

6.  Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.

Authors:  T Ishihara; M Higuchi; B Zhang; Y Yoshiyama; M Hong; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

Authors:  R W Shin; T Iwaki; T Kitamoto; J Tateishi
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

9.  Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.

Authors:  Jose J Jarero-Basulto; Jose Luna-Muñoz; Raul Mena; Zdena Kristofikova; Daniela Ripova; George Perry; Lester I Binder; Francisco Garcia-Sierra
Journal:  J Neuropathol Exp Neurol       Date:  2013-12       Impact factor: 3.685

10.  Motor and cognitive deficits in aged tau knockout mice in two background strains.

Authors:  Peng Lei; Scott Ayton; Steve Moon; Qihao Zhang; Irene Volitakis; David I Finkelstein; Ashley I Bush
Journal:  Mol Neurodegener       Date:  2014-08-14       Impact factor: 14.195

View more
  37 in total

Review 1.  The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Lili Zhang; Xiangyun Wei
Journal:  J Neurosci       Date:  2022-06-15       Impact factor: 6.709

2.  Activation of PI3k/Akt/mTOR Signaling Induces Deposition of p-tau to Promote Aluminum Neurotoxicity.

Authors:  Yirong Xu; Guangheng Zhang; Yingying Zhao; Fan Bu; Yeping Zhang
Journal:  Neurotox Res       Date:  2022-09-06       Impact factor: 3.978

3.  Post-translational Modifications in Brain Diseases: A Future for Biomarkers.

Authors:  Licia C Silva-Costa; Bradley J Smith
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 5.  The role of BAG3 in health and disease: A "Magic BAG of Tricks".

Authors:  Heng Lin; Shon A Koren; Gregor Cvetojevic; Peter Girardi; Gail V W Johnson
Journal:  J Cell Biochem       Date:  2021-05-14       Impact factor: 4.480

6.  Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease.

Authors:  Dongmei Chen; Guihua Lan; Ruomeng Li; Yingxue Mei; Xindong Shui; Xi Gu; Long Wang; Tao Zhang; Chen-Ling Gan; Yongfang Xia; Li Hu; Yuan Tian; Mi Zhang; Tae Ho Lee
Journal:  Transl Neurodegener       Date:  2022-05-09       Impact factor: 9.883

7.  Fyn depletion ameliorates tauP301L-induced neuropathology.

Authors:  Guanghao Liu; Kimberly L Fiock; Yona Levites; Todd E Golde; Marco M Hefti; Gloria Lee
Journal:  Acta Neuropathol Commun       Date:  2020-07-14       Impact factor: 7.801

Review 8.  Neuroprotective Natural Products for Alzheimer's Disease.

Authors:  Xin Chen; Joshua Drew; Wren Berney; Wei Lei
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

Review 9.  Current Status of Clinical Trials on Tau Immunotherapies.

Authors:  Changyi Ji; Einar M Sigurdsson
Journal:  Drugs       Date:  2021-06-08       Impact factor: 11.431

10.  Unsaturated Fatty Acid-Induced Conformational Transitions and Aggregation of the Repeat Domain of Tau.

Authors:  Carlo Giorgio Barracchia; Roberto Tira; Francesca Parolini; Francesca Munari; Luigi Bubacco; Georgios A Spyroulias; Mariapina D'Onofrio; Michael Assfalg
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.